Submitted by Anonymous (not verified) on 12 November 2025 - 15:30
Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Status: Authorised